Congratulations to Dr. Lori Hazlehurst. She is now a standing member of the Mechanisms of Cancer Therapeutics-2 study section for the National Institutes of Health (NIH) Center for Scientific Review (CSR). Her membership began July 1.
Congratulations to Dr. Lori Hazlehurst. She is now a standing member of the Mechanisms of Cancer Therapeutics-2 study section for the National Institutes of Health (NIH) Center for Scientific Review (CSR). Her membership began July 1.
